Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ewing sarcoma is characterized by the EWS-FLI1 fusion gene, which drives oncogenesis through altered gene expression.
• The precise mechanisms by which EWS-FLI1 regulates gene expression remain incompletely understood.

Purpose of the Study:

• To identify downstream gene targets of the EWS-FLI1 oncoprotein using RNA sequencing.
• To investigate the role of identified targets in Ewing sarcoma pathogenesis.

Main Methods:

• RNA sequencing (RNAseq) was performed on pediatric mesenchymal progenitor cells expressing EWS-FLI1.
• Functional assays were used to assess the impact of EWSAT1 inhibition on Ewing sarcoma cell proliferation and colony formation.
• RNA-binding protein interactions were analyzed.

Main Results:

• Ewing sarcoma-associated transcript 1 (EWSAT1), a long noncoding RNA, was found to be upregulated by EWS-FLI1.
• Inhibition of EWSAT1 reduced proliferation and colony formation in Ewing sarcoma cells.
• EWS-FLI1 and EWSAT1 cooperate to repress gene expression, with significant overlap in target genes.
• Heterogeneous nuclear ribonucleoprotein K (HNRNPK) was identified as an interacting protein involved in EWSAT1-mediated gene repression.

Conclusions:

• EWSAT1 is a key downstream effector of EWS-FLI1 in Ewing sarcoma.
• EWSAT1 facilitates Ewing sarcoma development by repressing target genes, potentially through interaction with HNRNPK.
• EWSAT1 represents a promising therapeutic target for Ewing sarcoma.